PLRX icon

Pliant Therapeutics

151 hedge funds and large institutions have $725M invested in Pliant Therapeutics in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 16 closing their positions.

Holders
151
Holders Change
+8
Holders Change %
+5.59%
% of All Funds
2.18%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
24
Increased
60
Reduced
31
Closed
16
Calls
$1.31M
Puts
$4.99M
Net Calls
-$3.69M
Net Calls Change
-$4.06M
Name Holding Trade Value Shares
Change
Shares
Change %
CC
151
Casdin Capital
New York
-$10.8M -1,000,000 Closed
PP
152
PDT Partners
New York
-$681K -63,352 Closed
Verition Fund Management
153
Verition Fund Management
Connecticut
-$607K -56,501 Closed
AGP
154
Artia Global Partners
Florida
-$538K -50,000 Closed
ACP
155
Acuta Capital Partners
California
-$497K -46,200 Closed
Balyasny Asset Management
156
Balyasny Asset Management
Illinois
-$343K -31,910 Closed
NRD
157
Nebula Research & Development
New York
-$268K -24,904 Closed
DTL
158
Dynamic Technology Lab
Singapore
-$188K -17,487 Closed
CC
159
Corton Capital
Ontario, Canada
-$172K -15,996 Closed
QT
160
Quantbot Technologies
New York
-$164K -15,261 Closed
DM
161
Deerfield Management
New York
-$126K -11,678 Closed
D.E. Shaw & Co
162
D.E. Shaw & Co
New York
-$115K -10,679 Closed
SSG
163
Summit Securities Group
New York
-$59K -5,532 Closed
Osaic Holdings
164
Osaic Holdings
Arizona
-$3.87K -360 Closed
QL
165
Quarry LP
New York
-$1.12K -104 Closed